NCT05004922

Brief Summary

The technique of embryo transfer is thought to affect the implantation and pregnancy rate .At present, the implantation site can be estimated from the location of the very early gestational sac by transvaginal ultrasound.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2019

Completed
2.5 years until next milestone

First Posted

Study publicly available on registry

August 13, 2021

Completed
19 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

August 13, 2021

Status Verified

August 1, 2021

Enrollment Period

4 months

First QC Date

February 3, 2019

Last Update Submit

August 11, 2021

Conditions

Infertility

Outcome Measures

Primary Outcomes (1)

  • number of women who will get pregnant in each group

    how many women will get pregnant after ICSI in every group

    within one month

Study Arms (2)

ICSI in upper cavity

Embryo transfer into the upper cavity

Other: Embryo transfer into upper cavity

ICSI in midcavity

Embryo transfer into the midcavity

Other: Embryo transfer into midcavity

Interventions

Embryo transfer into upper cavityOTHER

Transfer of embryos in upper cavity

Also known as: Gestational sac site after embryo transfer
ICSI in upper cavity
Embryo transfer into midcavityOTHER

Transfer of embryos in mid cavity

Also known as: Gestational sac site after embryo transfer
ICSI in midcavity

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen with infertility who will undergo ICSI
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

infertile women

You may qualify if:

  • AVF uterus. 2- BMI less than 30

You may not qualify if:

  • RVF uterus. 2- BMI more than 30.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Sherif Elsirgany, M.D

    Researcher, Family planning and Reproductive Health Department, NRC, Egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sherif Elsirgany, M.D

CONTACT

+201223607191sherifelsirgany@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher ,Family Planning and Reproductive Health Department

Study Record Dates

First Submitted

February 3, 2019

First Posted

August 13, 2021

Study Start

September 1, 2021

Primary Completion

January 1, 2022

Study Completion

February 1, 2022

Last Updated

August 13, 2021

Record last verified: 2021-08